Barinthus Biotherapeutics. (BRNS) Q1 2024 Earnings

13MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.62
-0.55
-0.47
-0.4

Details

Expected EPS
-0.54
Actual EPS
-0.4
Surprise EPS
0.14
Surprise Percent
+25.93%

Description

Barinthus Biotherapeutics. (BRNS) has reported earnings of -0.4 per share for Q1 2024.

0 Comments

Share your thoughts